Biotechnology
News
Sicor Biotech orders biotech facility from Pharmadule – 10-Mar-2010
Pharmadule has signed a contract with Sicor Biotech for the delivery of a biotech facility.
Abbott to acquire Facet Biotech – 10-Mar-2010
The deal provides a promising biologic to treat multiple sclerosis.
Wacker doubles production area at biologics plant – 8-Mar-2010
Wacker Chemie officially opens its new biologics plant in Jena, Germany.
Wacker Biosolutions to focus on biotechnology – 2-Mar-2010
Wacker Fine Chemicals becomes Wacker Biosolutions and concentrates on biotechnology
MediGene and Teva to commercialise Veregen – 22-Feb-2010
German biotech company MediGene has signed an agreement with Teva Pharmaceutical Industries for the supply and commercialisation of a genital warts treatment in Israel.
Technical
Fast track to tag-free proteins – 10-Sep-2009
Protein fusion technology using affinity tags has greatly simplified the process of purifying recombinant proteins. Now a single-step technology from Bio-Rad addresses the bottleneck in the subsequent tag removal process
A growing throw-away culture – 6-Apr-2009
Eric S Langer, president and managing partner of biotech marketing research company BioPlan Associates, highlights changes in attitudes to disposables use in biopharmaceutical manufacturing
Hyaluronic acid - the biotech way – 22-Dec-2008
Fanny Longin, science manager, Novozymes Biopolymer A/S, reveals why a new biotech method of producing hyaluronic acid is proving to be a winner
Small companies, big risk takers – 24-Jan-2008
A recent trip to Canada’s biotech sector in Saskatoon revealed a raft of drug-related innovations. Kirsty Osei-Bempong reports
Biologics - too late and too costly! – 26-Oct-2007
Avecia Biologics’ Bo Kara, director of science and technology and Stephen Taylor, director for business development, argue that the biotech sector needs to focus on reducing development time and its technology can help
Events
Pharma ChemOutsourcing – 22-Feb-2010
14 - 16 September 2010
Ocean Place Resort - Long Branch, NJ
The Synthetic Biology in Pharma conference – 9-Feb-2010
30 - 31 March 2010
The Wellcome Trust Conference Centre, Cambridge, UK
BioFine Europe 2010 – 9-Feb-2010
30 - 31 March
The Wellcome Trust Conference Centre, Cambridge, UK
The Bioprocessing Summit – 1-Feb-2010
23 - 26 August 2010
Boston Marriott Long Wharf Hotel, Boston, Massachusetts, US
Analytica 2010 – 22-Jan-2010
23 - 26 March 2010
Munich, Germany
Achema Asia – 20-Jan-2010
1 - 4 June 2010
Beijing, People's Republic of China
Jobs & People
Biocitech appoints new ceo – 8-Mar-2010
Jean-François Boussard becomes chief executive of French life science technology park on 1 April.
Revah joins Généthon as ceo – 23-Feb-2010
Généthon, a biotherapy research centre created by the French Muscular Dystrophy Association (AFM), has appointed Frédéric Revah as chief executive.
TxCELL appoints chief medical officer – 12-Feb-2010
TxCell, a French biotechnology company developing cell-based therapies using Type 1 T-regulatory lymphocytes for treating chronic inflammatory and autoimmune diseases, has appointed Miguel Forte to the newly created role of chief medical officer.
Syntaxin makes top appointments – 5-Feb-2010
Syntaxin, a UK developer of biopharmaceuticals that control cell secretion, has appointed Melanie Lee as chief executive.